TABLE 1.
Patient characteristics before the start of treatment
| Patient characteristic | Value for groupa |
P | |
|---|---|---|---|
| TB-DM (n = 18) | TB (n = 18) | ||
| No. (%) male | 7 (39) | 8 (44) | 1.00b |
| Age (yr) | 47 (8) | 35 (10) | 0.00c |
| Body wt (kg) | 47.3 (7.0) | 47.3 (7.2) | 0.85c |
| BMI (kg/m2) | 20.3 (3.5) | 19.6 (3.0) | 0.49c |
| Drug dose (mg/kg of body wt) | |||
| Rifampin | 9.7 (1.6) | 9.6 (1.6) | 0.82c |
| Ethambutol | 16.2 (2.7) | 16.1 (2.6) | 0.86c |
| Pyrazinamide | 32.5 (5.5) | 32.2 (5.2) | 0.86c |
| Fasting blood glucose (mmol/liter) | 16.6 (3.3) | 5.6 (1.6) | 0.00c |
| HbA1c (%) | 11.1 (2.2) | ||
| No. (%) with the following clinical manifestation: | |||
| Cough | 18 (100) | 18 (100) | |
| Hemoptysis | 8 (44) | 4 (22) | |
| Shortness of breath | 15 (83) | 17 (94) | |
| Fever | 15 (83) | 14 (79) | |
| Loss of wt | 16 (89) | 13 (72) | |
| Positive sputum smear | 16 (89) | 18 (100) | |
| Positive M. tuberculosis culture | 16 (89) | 18 (100) | |
a
Unless otherwise specified, data are given as means (standard deviations).
b
By Pearson's chi-square test.
c
By an independent t test.